Thrombolysis in myocardial infarction (TIMI) risk score validation in Saudi Arabia

Albugami, Saad; Al-Husayni, Faisal; Alamri, Samer Abdulmoghny; Aljedaani, Rakan M.; Zwawy, Mohammad A; Al-Zahrani, Abdullah S.

doi:10.4172/2368-0512.1000101

Curr Res Cardiol

2018

DOI: 10.4172/2368-0512.1000101

|View full text |Cite

Thrombolysis in myocardial infarction (TIMI) risk score validation in Saudi Arabia

Saad Albugami¹,

Faisal Al-Husayni²,

Samer Abdulmoghny Alamri³

et al.

Abstract: BACKGROUND:Early risk stratification plays a pivotal role in the optimal management of non-ST segment elevation myocardial infarction/unstable angina (NSTEMI/UA) acute coronary syndromes and certainly improving patients care and their final outcomes. Thrombolysis in myocardial infarction (TIMI) risk score was developed from randomized clinical trials on patients with NSTEMI and UA, and it has been validated in non-selected Western patient populations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2023

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Outcomes of percutaneous coronary intervention among patients with coronary artery disease in Saudi Arabia

Bugami¹,

Bashaweih²,

Hijazi³

et al. 2019

JCCR

Self Cite

View full text Add to dashboard Cite

Background: There is no published risk score model to predict mortality and morbidity following Percutaneous Coronary Intervention in Saudi Arabia. We aim to identify risk predictors that can estimates risks associated with percutaneous coronary intervention (PCI) specific to Saudi population that can be incorporated in creation of a population specific risk model. Methods: Data of 418 patients who were treated with percutaneous coronary intervention at king faisal cardiac center (KFCC) were retrospectively collected from January 2015 till December 2017. Demographics and clinical data were measured to define clinical predictors associated with in hospital death and Major Adverse Cardiac Events (MACE). Results: The study included 418 patients who underwent PCI between January 2015 until December 2017. The majority of the patients were of Saudi nationality (92.4%). The mean age was 60.58 (±7.8). Out of the study subjects, 225 (53.8%) were 60 years of age and above. Majority were male 315 (75.36%). The most prevalent pre-procedural risk factors were hypertension in 82%, Diabetes Mellitus in 74.52%, and dyslipidaemia in 70.7% of patients. Non-ST-elevation myocardial infarction was the major presentation with a percentage of 58.39%. The PCI status among the patients was divided into 38.35% urgent PCI, 35.19% elective PCI, and 26.46% primary PCI. In-hospital mortality occurred in a total of 5 patients (1.2%). Nineteen patients (4.5 %) experienced post-procedural complications. Intra procedural cardiac arrest occurred in 5 patients (1.2%). four patients (0.96%) required blood transfusion three of them due to post procedure bleeding. Other procedure related complications were as follows, cardiac tamponade (0.49%), stroke (0.73%), contrast allergy (0.24%), contrast nephropathy (0.73%), new requirement for dialysis (0.49%), and death in Cath lab (0.24%). Dyslipidaemia, previous renal disease, PCI indication, cardiogenic shock, pre and post-procedural haemoglobin level as well as post-procedural creatinine level showed significate relationship with in hospital MACE. Conclusion: Our findings suggest favourable outcomes of patients treated with PCI, matching the international data. We have identified certain risk predictors that need to be confirmed by large scale and prospective data In order to generate a population specific risk score model.

show abstract

Outcomes of percutaneous coronary intervention among patients with coronary artery disease in Saudi Arabia

Bugami¹,

Bashaweih²,

Hijazi³

et al. 2019

JCCR

Self Cite

View full text Add to dashboard Cite

show abstract

Validity of TIMI Risk Score and HEART Score for Risk Assessment of Patients with Unstable Angina/Non-ST Elevation Myocardial Infarction Presented to an Emergency Department in Jordan

Ababneh,

Smadi,

Al-Kasasbeh

et al. 2023

OAEM

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Thrombolysis in myocardial infarction (TIMI) risk score validation in Saudi Arabia

Cited by 2 publications

References 13 publications

Outcomes of percutaneous coronary intervention among patients with coronary artery disease in Saudi Arabia

Outcomes of percutaneous coronary intervention among patients with coronary artery disease in Saudi Arabia

Validity of TIMI Risk Score and HEART Score for Risk Assessment of Patients with Unstable Angina/Non-ST Elevation Myocardial Infarction Presented to an Emergency Department in Jordan

Contact Info

Product

Resources

About